MedicaMap covers common medicines like metformin, clopidogrel, warfarin, codeine, and many other medicines commonly used by Indians
MapMyGenome has launched its pharmacogenomics solution MedicaMap. Dr Annie Q Hasan, Founder & President of the Board of Genetic Counseling India, gave the keynote speech.
She said, “Medicines are usually prescribed using a ‘one-size-fits-all’ approach. But variations in individuals’ DNA lead to variations in their response to medication.”
Anu Acharya, CEO, MapMyGenome said, “MedicaMap is a one-of-a-kind pharmacogenomic product which provides you a detailed analysis of your body’s response to medicine based on your genetic makeup. It is affordable, non-invasive, and once-in-a-lifetime. You can do it from your own home. We have introduced it at Rs 6499 for over 165 drugs, which is probably the lowest price.”
MedicaMap is MapMyGenome’s cutting-edge pharmacogenomic solution that analyses an individual’s response to medicines, based on genetic makeup. This pharmacogenomic solution analyses 165+ US-FDA-approved drugs across 12 different specialities such as psychiatry, oncology, cardiology, diabetology, and many more.
According to a study published in The Pharmacogenomics Journal, Indians have a higher risk for medicine-induced heart-related cases compared with the West. The study also shows Indians’ varied responses to widely used medicines like warfarin (anti-coagulant drugs), metformin (diabetes drug), and clopidogrel (antiplatelet drug). The varied response to medicines among Indians highlights the significance of creating India-specific comprehensive pharmacogenomic data.
MedicaMap covers common medicines like metformin, clopidogrel, warfarin, codeine, and many other medicines commonly used by Indians.
MedicaMap gives an easy-to-read comprehensive report on medicines’ toxicity and efficacy for a person. It helps clinicians to identify alternate medicine or adjust the dosage according to an individual’s genetic profile for the prevention, diagnosis, and treatment of any health condition.